Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly McQuarrie

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The Journal of Urology|May 27, 2021
Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer: Analysis of Pain and Fatigue in the Phase 3 TITAN StudyNeeraj Agarwal, Kelly McQuarrie, Anders Bjartell, et al.
The Journal of Urology|July 23, 2021
Reply by AuthorsNeeraj Agarwal, Kelly McQuarrie, Anders Bjartell, et al.
The Lancet. Oncology|October 4, 2019
Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 studyNeeraj Agarwal, Kelly McQuarrie, Anders Bjartell, et al.
Clinical Therapeutics|April 5, 2016
Patient-reported Symptoms of Tenosynovial Giant Cell TumorsHeather L Gelhorn, Sandra Tong, Kelly McQuarrie, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The Journal of Urology|May 27, 2021
Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer: Analysis of Pain and Fatigue in the Phase 3 TITAN StudyNeeraj Agarwal, Kelly McQuarrie, Anders Bjartell, et al.
The Journal of Urology|July 23, 2021
Reply by AuthorsNeeraj Agarwal, Kelly McQuarrie, Anders Bjartell, et al.
The Lancet. Oncology|October 4, 2019
Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 studyNeeraj Agarwal, Kelly McQuarrie, Anders Bjartell, et al.
Clinical Therapeutics|April 5, 2016
Patient-reported Symptoms of Tenosynovial Giant Cell TumorsHeather L Gelhorn, Sandra Tong, Kelly McQuarrie, et al.
Pageof 3